Previous 10 | Next 10 |
MIAMI BEACH, Fla, April 21, 2022 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS), a national provider of premium body contouring procedures, today announced that the company will release its first quarter results before market open on Friday, May ...
AirSculpt Technologies, Inc. (AIRS) Q4 2021 Earnings Conference Call March 11, 2022, 08:00 AM ET Company Participants Aaron Rollins - Chief Executive Officer Dennis Dean - Chief Financial Officer Ronald Zelhof - Chief Operating Officer Conference Call Participants Simeon Gutman - Morgan Stanl...
AirSculpt Technologies press release (NASDAQ:AIRS): Q4 Revenue of $37.56M (+64.4% Y/Y) beats by $3.04M. Cases increased 43.8% from prior year period to 2,885 cases. Same-center revenue per case increased 13.1% from the prior year period. Same-center cases increased 19.6% from the prior year p...
MIAMI BEACH, Fla., March 11, 2022 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the fourth quarter and full year ended December ...
MIAMI BEACH, Fla., Feb. 18, 2022 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS) today announced that the company will release its fourth quarter and full year results before market open on Friday, March 11, 2022, to be followed by a conference ca...
AirSculpt Technologies, Inc. (AIRS) Q3 2021 Earnings Conference Call December 03, 2021, 08:30 AM ET Company Participants Dennis Dean - CFO Aaron Rollins - CEO Ronald P. Zelhof - COO Conference Call Participants Simeon Gutman - Morgan Stanley Whit Mayo - SVB Leerink Parker Snure - Raymond Jame...
Gainers: Celyad Oncology CYAD +41%, Longeveron LGVN +28%, Petros Pharmaceuticals (NASDAQ:PTPI) +26%, AirSculpt Technologies AIRS +12%, Werewolf Therapeutics (NASDAQ:HOWL) +12%. Losers: Esperion Therapeutics ESPR -40%, Biofrontera (NASDAQ:...
The shares of AirSculpt Technologies (AIRS +7.2%) have recorded a double-digit gain in percentage terms after reporting better-than-anticipated revenue for Q3 2021 and setting its 2021 outlook slightly ahead of expectations. The healthcare service provider focused on fat removal procedures sa...
AirSculpt Technologies (NASDAQ:AIRS): Q3 Net Income of $8.1M Revenue of $34.65M (+94.3% Y/Y) beats by $0.46M. Shares -6.02% AH. Press Release The Company projects full year revenue to be approximately $130 million vs consensus of $129.82M and full year Adjusted EBITDA to be approximately...
MIAMI BEACH, Fla., Dec. 03, 2021 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the third quarter ended September 30, 2021. ...
News, Short Squeeze, Breakout and More Instantly...
AirSculpt Technologies Inc. Company Name:
AIRS Stock Symbol:
NASDAQ Market:
AirSculpt Technologies Inc. Website:
Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...
MIAMI BEACH, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) (“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2024. Firs...